133 related articles for article (PubMed ID: 36778323)
1. A multiomics approach to understanding pathology of Combined D,L-2- Hydroxyglutaric Aciduria and phenylbutyrate as potential treatment.
Phua YL; D'Annibale OM; Karunanidhi A; Mohsen AW; Kirmse B; Dobrowolski SF; Vockley J
bioRxiv; 2023 Feb; ():. PubMed ID: 36778323
[TBL] [Abstract][Full Text] [Related]
2. A multiomics approach reveals evidence for phenylbutyrate as a potential treatment for combined D,L-2- hydroxyglutaric aciduria.
Phua YL; D'Annibale OM; Karunanidhi A; Mohsen AW; Kirmse B; Dobrowolski SF; Vockley J
Mol Genet Metab; 2024 May; 142(3):108495. PubMed ID: 38772223
[TBL] [Abstract][Full Text] [Related]
3. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
[TBL] [Abstract][Full Text] [Related]
4. Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) Deficiency.
Smith A; McBride S; Marcadier JL; Michaud J; Al-Dirbashi OY; Schwartzentruber J; Beaulieu CL; Katz SL; ; Majewski J; Bulman DE; Geraghty MT; Harper ME; Chakraborty P; Lines MA
JIMD Rep; 2016; 30():73-79. PubMed ID: 27306203
[TBL] [Abstract][Full Text] [Related]
5. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
[TBL] [Abstract][Full Text] [Related]
7. Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.
Prasun P; Young S; Salomons G; Werneke A; Jiang YH; Struys E; Paige M; Avantaggiati ML; McDonald M
JIMD Rep; 2015; 19():111-5. PubMed ID: 25614306
[TBL] [Abstract][Full Text] [Related]
8. A
Li H; Hurlburt AJ; Tennessen JM
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108060
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
Majd H; King MS; Smith AC; Kunji ERS
Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
[TBL] [Abstract][Full Text] [Related]
10. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
Pop A; Williams M; Struys EA; Monné M; Jansen EEW; De Grassi A; Kanhai WA; Scarcia P; Ojeda MRF; Porcelli V; van Dooren SJM; Lennertz P; Nota B; Abdenur JE; Coman D; Das AM; El-Gharbawy A; Nuoffer JM; Polic B; Santer R; Weinhold N; Zuccarelli B; Palmieri F; Palmieri L; Salomons GS
J Inherit Metab Dis; 2018 Mar; 41(2):169-180. PubMed ID: 29238895
[TBL] [Abstract][Full Text] [Related]
11. Disruption of mitochondrial bioenergetics, calcium retention capacity and cell viability caused by D-2-hydroxyglutaric acid in the heart.
Ribeiro RT; Roginski AC; Marschner RA; Wajner SM; Castilho RF; Amaral AU; Wajner M
Biochimie; 2023 Apr; 207():153-164. PubMed ID: 36372308
[TBL] [Abstract][Full Text] [Related]
12. Disease-related metabolites in culture medium of fibroblasts from patients with D-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria, and combined D/L-2-hydroxyglutaric aciduria.
Struys EA; Verhoeven NM; Roos B; Jakobs C
Clin Chem; 2003 Jul; 49(7):1133-8. PubMed ID: 12816910
[TBL] [Abstract][Full Text] [Related]
13. Loss of the mitochondrial carrier,
Kasprzyk-Pawelec A; Tan M; Rahhal R; McIntosh A; Fernandez H; Mosaoa R; Jiang L; Pearson GW; Glasgow E; Vockley J; Albanese C; Avantaggiati ML
bioRxiv; 2024 May; ():. PubMed ID: 37503155
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of human D-2-hydroxyglutarate dehydrogenase and two disease related variants reveals the molecular cause of D-2-hydroxyglutaric aciduria.
Toplak M; Brunner J; Schmidt J; Macheroux P
Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140255. PubMed ID: 31349060
[TBL] [Abstract][Full Text] [Related]
15. L-2-hydroxyglutaric aciduria, a defect of metabolite repair.
Rzem R; Vincent MF; Van Schaftingen E; Veiga-da-Cunha M
J Inherit Metab Dis; 2007 Oct; 30(5):681-9. PubMed ID: 17603759
[TBL] [Abstract][Full Text] [Related]
16. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria.
Rzem R; Veiga-da-Cunha M; Noël G; Goffette S; Nassogne MC; Tabarki B; Schöller C; Marquardt T; Vikkula M; Van Schaftingen E
Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16849-54. PubMed ID: 15548604
[TBL] [Abstract][Full Text] [Related]
17. Novel cases of D-2-hydroxyglutaric aciduria with IDH1 or IDH2 mosaic mutations identified by amplicon deep sequencing.
Nota B; Hamilton EM; Sie D; Ozturk S; van Dooren SJ; Ojeda MR; Jakobs C; Christensen E; Kirk EP; Sykut-Cegielska J; Lund AM; van der Knaap MS; Salomons GS
J Med Genet; 2013 Nov; 50(11):754-9. PubMed ID: 24049096
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria.
Struys EA; Salomons GS; Achouri Y; Van Schaftingen E; Grosso S; Craigen WJ; Verhoeven NM; Jakobs C
Am J Hum Genet; 2005 Feb; 76(2):358-60. PubMed ID: 15609246
[TBL] [Abstract][Full Text] [Related]
19. L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair.
Van Schaftingen E; Rzem R; Veiga-da-Cunha M
J Inherit Metab Dis; 2009 Apr; 32(2):135-42. PubMed ID: 19020988
[TBL] [Abstract][Full Text] [Related]
20. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
